Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Olaf Müller a Department of Tropical
Hygiene and Public Health, Ruprecht Karls University, 69120 Heidelberg,
INF 324, Germany, b Centre de Recherche en Santé de Nouna, Nouna,
Burkina Faso, c Centre National de Recherche et
de Formation sur le Paludisme, Ouagadougou, Burkina Faso, d Centre Français sur la
Population et le Dévelopement, 75270 Paris, Cedex 06, France
Correspondence to: O Müller olaf.mueller{at}urz.uni-heidelberg.de
Objective:
To study the effects of zinc
supplementation on malaria and other causes of morbidity in young
children living in an area holoendemic for malaria in west Africa.
What is already known on this topic
What this study adds
Design:
Randomised, double blind, placebo controlled efficacy trial.
Setting:
18 villages in rural northwestern Burkina Faso.
Participants:
709 children were enrolled; 685 completed the trial.
Intervention:
Supplementation with zinc (12.5 mg zinc
sulphate) or placebo daily for six days a week for six months.
Main outcome measures:
The primary outcome was the
incidence of symptomatic falciparum malaria. Secondary outcomes were
the severity of malaria episodes, prevalence of malaria parasite, mean
parasite densities, mean packed cell volume, prevalence of other
morbidity, and all cause mortality.
Results:
The mean number of malaria episodes per child (defined as a temperature
37.5°C with
5000 parasites/µl)
was 1.7, 99.7% due to infection with Plasmodium
falciparum. No difference was found between the zinc and placebo
groups in the incidence of falciparum malaria (relative risk 0.98, 95%
confidence interval 0.86 to 1.11), mean temperature, and mean parasite
densities during malaria episodes, nor in malaria parasite rates, mean
parasite densities, and mean packed cell volume during cross sectional surveys. Zinc supplementation was significantly associated with a
reduced prevalence of diarrhoea (0.87, 0.79 to 0.95). All cause mortality was non-significantly lower in children given zinc compared with those given placebo (5 v 12, P=0.1).
Conclusions:
Zinc supplementation has no effect on
morbidity from falciparum malaria in children in rural west Africa, but it does reduce morbidity associated with diarrhoea.
Zinc deficiency is common in infants in developing countries
Zinc supplementation has no effect on falciparum malaria in children in
rural west Africa